HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β.

AbstractOBJECTIVE:
Kawasaki disease (KD) is the most common cause of acute vasculitis and acquired cardiac disease among US children. We have previously shown that both TLR2/MyD88 and interleukin (IL)-1β signaling are required for the Lactobacillus casei cell wall extract-induced KD vasculitis mouse model. The objectives of this study were to investigate the cellular origins of IL-1 production, the role of CD11c(+) dendritic cells and macrophages, and the relative contribution of hematopoietic and stromal cells for IL-1 responsive cells, as well the MyD88 signaling, in Lactobacillus casei cell wall extract-induced KD mouse model of vasculitis.
APPROACH AND RESULTS:
Using mouse knockout models and antibody depletion, we found that both IL-1α and IL-1β were required for Lactobacillus casei cell wall extract-induced KD. Both dendritic cells and macrophages were necessary, and we found that MyD88 signaling was required in both hematopoietic and stromal cells. However, IL-1 response and signaling were critically required in nonendothelial stromal cells, but not in hematopoietic cells.
CONCLUSIONS:
Our results suggest that IL-1α and IL-1β, as well as CD11c(+) dendritic cells and macrophages, are essential for the development of KD vasculitis and coronary arteritis in this mouse model. Bone marrow chimera experiments suggest that MyD88 signaling is important in both hematopoietic and stromal cells, whereas IL-1 signaling and response are required only in stromal cells, but not in endothelial cells. Determining the role of IL-1α and IL-1β and of specific cell types in the KD vasculitis mouse model may have important implications for the design of more targeted therapies and understanding of the molecular mechanisms of KD immunopathologies.
AuthorsYoungho Lee, Daiko Wakita, Jargalsaikhan Dagvadorj, Kenichi Shimada, Shuang Chen, Ganghua Huang, Thomas J A Lehman, Michael C Fishbein, Hal M Hoffman, Timothy R Crother, Moshe Arditi
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 35 Issue 12 Pg. 2605-16 (Dec 2015) ISSN: 1524-4636 [Electronic] United States
PMID26515418 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2015 American Heart Association, Inc.
Chemical References
  • Aim2 protein, mouse
  • Carrier Proteins
  • DNA-Binding Proteins
  • IL1B protein, mouse
  • IL1R1 protein, mouse
  • Interleukin-1alpha
  • Interleukin-1beta
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, mouse
  • Receptors, Interleukin-1 Type I
  • Caspase 1
Topics
  • Animals
  • Aorta (metabolism, pathology)
  • Aortitis (chemically induced, genetics, metabolism, pathology)
  • Bone Marrow Cells (metabolism)
  • Bone Marrow Transplantation
  • Carrier Proteins (metabolism)
  • Caspase 1 (metabolism)
  • Cell Wall
  • Cells, Cultured
  • Coronary Artery Disease (chemically induced, genetics, metabolism, pathology)
  • Coronary Vessels (metabolism, pathology)
  • DNA-Binding Proteins (genetics, metabolism)
  • Dendritic Cells (metabolism)
  • Disease Models, Animal
  • Endothelial Cells (metabolism)
  • Interleukin-1alpha (metabolism)
  • Interleukin-1beta (metabolism)
  • Lacticaseibacillus casei
  • Macrophages (metabolism)
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mucocutaneous Lymph Node Syndrome (chemically induced, genetics, metabolism, pathology)
  • Myeloid Differentiation Factor 88 (genetics, metabolism)
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Receptors, Interleukin-1 Type I (genetics, metabolism)
  • Signal Transduction
  • Stromal Cells (metabolism, pathology)
  • Transplantation Chimera

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: